Isomorphic Labs Raises $5 Billion Series C, the Largest Biotech Venture Round Ever
Isomorphic Labs, the DeepMind spin-out, has raised $5bn in a Series C co-led by Greenoaks and Sequoia to take its AI-designed drug candidates to clinical trials — the largest venture round in biotech history.

Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials. The round was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining as a new investor alongside Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. It follows a $2.1 billion Series B in May, and is the largest venture round in biotech history, surpassing the $3 billion Altos Labs raised at its 2022 launch. The funding will develop IsoDDE, Isomorphic's drug-design engine, and build AI-led clinical infrastructure. Founder and CEO Demis Hassabis has said the company expects its first clinical trials by the end of 2026.
TechCrunch
techcrunch.com
More from the newsroom
All news
Endeavor Pakistan Board Meets PM Shehbaz Sharif on Fund of Funds for Startups
Endeavor Pakistan's board met Prime Minister Shehbaz Sharif in Islamabad to discuss a fund of funds and help for growth-stage founders — with a World Bank-backed $50m fund of funds already being planned.

Pakistan's IT Exports Hit a Record $453 Million in October
Pakistan's IT exports hit a record $453m in October 2026, up 17.4% year on year, taking July–October earnings to $1.699bn, according to State Bank of Pakistan data.

Genesis AI Raises $500 Million Series A at $3.5 Billion Valuation
Genesis AI has raised $500m in a Series A at a $3.5bn valuation, co-led by Premji Invest, Khosla Ventures and Eclipse, to scale production of its Eno general-purpose robot and the AI that trains it.